Guest: Larry Culpepper, MD, MPH

Insomnia is one of the most common sleep disturbances with significant negative impacts on patients' everyday functioning and quality of life. Patients with chronic insomnia are more likely to develop affective disorders, cardiac morbidity, and other adverse health outcomes, yet it is under-recognized and under treated. This case-based CME activity “Insomnia and Comorbidity High Risk with Poor Outcomes” will take clinicians through several patients journeys to examine the relationships between insomnia and common comorbidities including cardiovascular disease, diabetes and psychiatric disorders. Clinicians will apply the latest understanding of the pathophysiology of sleep and wake disorders to individualize the management of each patient, using a variety of approaches including newer agents such as orexin antagonist, melatonin receptor agonist, sedating antidepressant or benzodiazepine.